Upregulation via histone deacetylase inhibitors enhances motor neuron resistance to stress-induced damage [84], and regional differences in HSP expression and inflammation in ALS may influence disease progression [85], supporting the potential of HSP-modulating therapies, as shown here. This evidence concerns the gene HSP90B2P and amyotrophic lateral sclerosis.